Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Ryder(R) ACCESSWIRE Newsroom·2025-01-17 22:25文章核心观点 - 文章是博士康公司（Bausch Health）关于利福昔明（XIFAXAN(R)(rifaximin)）被选入《降低通胀法案》医保谈判计划的声明 [1]